Adding cetuximab to bevacizumab unhelpful in colorectal cancer
Dutch oncologists have found that adding the EGFR inhibitor cetuximab to a combination of chemotherapy plus bevacizumab results in worse progression-free survival and lower quality of life in patients with metastatic colorectal cancer....
Want to read complete article? Please Sign in or Register.